Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On this page, we’ll provide an overview of the Suboxone Tooth Decay MDL, responses from pharmaceutical companies in the Suboxone Tooth Decay MDL, whether or not you can still join the Suboxone Tooth Decay MDL, and much more.
To determine your eligibility for the MDL, consider the following:
If you or a loved one has experienced severe tooth decay, deteriorating dental health, or dental injuries after taking Suboxone, you may be entitled to pursue compensation for your damages.
Contact TruLaw using the chat on this page for a free and instant case evaluation to find out if you qualify to join others filing in the Suboxone Tooth Decay MDL.
On this page, we’ll discuss an overview of the Suboxone tooth decay lawsuits, the implications for those taking opioid addiction medication, aspects related to dental health, issues concerning prescription Suboxone film, and considerations regarding Suboxone sublingual films, and much more.
The Suboxone Tooth Decay MDL specifically addresses allegations that Suboxone sublingual films — used as a treatment for opioid addiction — may cause significant dental health issues, such as tooth decay.
Individuals who have been prescribed this medication and subsequently experienced dental problems have commenced legal actions, which have been consolidated into a Multidistrict Litigation (MDL).
This MDL centralizes pretrial proceedings with the aim of dealing with numerous cases that share common factual questions, thus providing efficiency and consistency in the rulings.
As with any MDL, people often wonder if they can join the suboxone lawsuits even after the litigation has commenced.
The answer to this does vary, but here’s what prospective plaintiffs should know:
Suboxone tooth decay lawsuits continue to develop, and plaintiffs seek recovery for the harm they’ve suffered both physically and financially due to dental problems.
Suboxone teeth lawsuits shine a light on the potential side effects of opioid addiction medication and stress the importance of informed consent and awareness of medication risks.
Staying informed of the latest developments in the Suboxone MDL is essential for those affected and considering joining the litigation.
As the situation evolves, additional information becomes available, offering further guidance for prospective plaintiffs.
Recent studies and patient reports have highlighted a concerning link between the use of Suboxone, particularly in strip form, and the development of severe dental issues.
These problems range from enamel erosion to tooth decay.
The formulation of Suboxone strips, designed to dissolve sublingually, has been associated with an increase in dental caries and the erosion of tooth enamel.
Research indicates that the way Suboxone is administered may erode tooth enamel, leading to significant dental injuries.
Suboxone-related dental complications typically manifest as:
The FDA has issued warnings about the potential for dental problems associated with medications like Suboxone that dissolve in the mouth due to the oral health issues reported in patients with no prior history of dental problems.
As more patients use Suboxone for opioid dependency treatment, dental practitioners are noting an uptick in dental injuries related to its use.
It is essential for patients and healthcare providers to be aware of the potential dental side effects.
Reports of Suboxone-related dental issues have highlighted:
The case series published by the National Institutes of Health underscores the necessity for further investigation into the relationship between Suboxone use and detrimental effects on oral health.
The state of Ohio has been active in addressing the alleged link between Suboxone usage and dental issues.
Recent developments highlight the legal processes Midwest residents face when dealing with Suboxone tooth decay litigation.
Multidistrict litigation (MDL) has been established to address claims related to Suboxone, a medication used to treat opioid addiction that has been associated with oral health problems, such as tooth decay.
The MDL 3092 has centralized numerous federal suboxone lawsuits alleging that the Suboxone film causes dental erosion and decay.
Suboxone class action lawsuits have also emerged, with plaintiffs seeking compensation for damages due to these dental conditions.
In Ohio, the status of this litigation has seen steady progress, with recent developments focusing on:
The MDL has been transferred to the Northern District of Ohio to streamline the pretrial procedures for all related cases.
Suboxone tooth decay lawyers specializing in pharmaceutical litigation, like those from TruLaw, play a pivotal role in shaping the outcome of the Suboxone tooth decay litigation.
Their responsibilities include:
Suboxone Lawyers work to ensure that those affected by the potentially damaging side effects of Suboxone receive fair representation in the justice system.
Patients who have been prescribed Suboxone, a medication typically used for opioid addiction treatment, have reported a range of oral health problems.
These personal accounts often emphasize the severity of dental conditions and the consequent impact on lifestyle and health.
Personal narratives often shed light on the extent of dental damage attributed to the use of Suboxone.
Reports include:
The impact of these dental problems goes beyond mere discomfort.
Consider the following ways dental problems can negatively impact your life:
When prescribing Suboxone for opioid addiction treatment, healthcare professionals must balance efficacy with potential risks, including adverse dental outcomes.
Suboxone combines buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist.
It’s administered to mitigate withdrawal symptoms and cravings in individuals struggling with opioid dependence.
Typically prescribed in two forms, it comes as a prescription suboxone film that dissolves under the tongue and as a suboxone tablet.
Suboxone’s key components work together to address opioid dependence:
Physicians prescribing Suboxone must be certified, ensuring they have adequate knowledge of opioid addiction and are aware of both the benefits and risks associated with its use.
Key responsibilities include:
Research has highlighted a link between the long-term use of Suboxone, specifically the sublingual films, and dental issues such as tooth decay and erosion.
It’s imperative that providers monitor patients for these adverse outcomes.
Monitoring strategies:
When addressing opioid addiction, it is crucial to handle the prescription of Suboxone with utmost care.
This involves recognizing its significance in recovery while also managing potential dental risks.
In the context of the Multi-District Litigation (MDL) concerning Suboxone tooth decay, drug manufacturers have issued statements and faced analysis surrounding product liability issues.
Suboxone drug manufacturers have publicly addressed the tooth decay claims linked to their products.
They often stress their commitment to patient safety and the importance of providing adequate warnings:
Recent lawsuits allege that Suboxone film, a medication used to treat opioid dependence, causes serious dental problems due to a lack of sufficient warnings.
Plaintiffs argue manufacturers failed to adequately inform patients and doctors about the risks.
Legal experts and analysts weighing in on the product liability lawsuits against Suboxone manufacturers have pointed out several key areas of concern:
When addressing opioid addiction, a nuanced approach is necessary to consider both the efficacy of treatments and their potential health implications.
Sublingual strips used to treat opioid addiction, such as Suboxone (a combination of sublingual buprenorphine and naloxone), have been associated with dental health issues.
The FDA warns of the risk that these sublingual medications can cause dental problems.
Some key concerns to be aware of are:
Various medications are available to treat opioid addiction.
These include:
Sublingual buprenorphine-naloxone can dry out the mouth, reducing saliva flow and increasing the risk of tooth decay and gum disease.
Therefore, healthcare providers assess several factors to determine a patient’s risk of dental complications.
When evaluating the risk of dental complications, healthcare providers consider the following:
It’s essential for patients undergoing treatment for opioid use disorder to receive regular dental check-ups to monitor and address any emerging oral health issues.
Maintaining optimal dental health is essential for patients on Suboxone to prevent issues such as tooth decay and oral infections.
This section offers concrete steps and collaborative strategies to safeguard oral health.
Proper oral hygiene can significantly reduce the risk of dental problems.
Below are four essential practices:
A team-based approach can enhance the delivery of preventative care.
Here are key collaborative measures:
By incorporating these best practices into daily routines and adopting a collaborative care model, patients on Suboxone can better protect their oral health and prevent serious dental issues.
When patients face dental issues potentially connected to Suboxone use, they may consider seeking compensation through a legal claim.
This section outlines how individuals can navigate the Suboxone claims process and underlines the importance of legal consultation.
Navigating the Suboxone claims process demands a structured approach to ensure all the requisite steps are meticulously followed.
The following are integral steps in the process:
Securing professional legal advice is essential for addressing Suboxone-related dental problems.
Here’s what patients need to do:
The opioid epidemic has cast a shadow over numerous aspects of public health, including dental wellness, revealing a troubling connection between opioid dependence and various dental problems.
This section explores the detrimental impact of opioid misuse on oral health.
Opioid addiction often leads to neglect of personal hygiene routines, including oral care, which can culminate in significant dental issues.
The commonly prescribed medication for opioid dependence, such as buprenorphine (found in medications like Suboxone), has been linked to oral health side effects.
To underline the correlation, observe the following:
The enhancement of dental wellness in the midst of the opioid crisis necessitates a comprehensive approach that addresses the underlying causes of addiction and the resultant health implications.
A dual strategy encompassing treatment interventions and educational initiatives emphasizing the significance of oral health stands to effectively alleviate these formidable challenges.
To join the Suboxone tooth decay lawsuit, individuals must have used Suboxone and subsequently suffered from dental issues, such as tooth decay or tooth loss.
Documentation of medical treatment for these dental issues may be required to establish a connection to Suboxone usage.
The potential compensation for affected individuals may cover dental treatment costs, pain and suffering, and other damages resulting from Suboxone-related tooth decay.
The exact compensation will vary based on individual circumstances and the lawsuit’s outcome.
To sign up for the lawsuit, interested parties should contact a qualified attorney specializing in pharmaceutical litigation.
They will help to determine eligibility and guide through the process of joining the multidistrict litigation (MDL).
Each lawsuit has specific deadlines, known as statutes of limitations, which vary by state.
It’s crucial to consult an attorney promptly to avoid missing these deadlines and ensure participation in the legal action.
If a settlement is reached, distribution to claimants will follow a plan approved by the court.
Each claimant’s share will depend on the extent of their dental damage and other individual factors considered during the litigation process.
Recent legal developments in the Suboxone case include ongoing proceedings in the multidistrict litigation.
Individuals should regularly check announcements from the Federal Drug Administration or court documents pertaining to the case for the latest updates.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Suboxone Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?